NCT05562739

Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety

A Randomized, Double-blinded, Placebo-controlled, Parallel Pilot Study, to Assess the Effect of a Postbiotic Blend on Symptoms of Anxiety in Healthy Adults with Self-reported Mild to Moderate Anxiety

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: The Archer-Daniels-Midland Company · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the efficacy of a multistrain postbiotic administered in the form of a capsule in the management of moderate self-reported anxiety in adults aged 18-65

Detailed description

The subjects will be placebo non-responders from part 1 of the trial, looking at the effect of a multistrain probiotic on anxiety.

Conditions

• Anxiety

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Postbiotic	multistrain postbiotic in the form of a capsule with a daily dose of 1E+9 Colony Forming Unit (CFU) per day for 6 weeks.
DIETARY_SUPPLEMENT	Placebo	Matching placebo in a form of a capsule for 6 weeks.

Timeline

• Start date: 2024-01-04
• Primary completion: 2024-02-28
• Completion: 2024-02-28
• First posted: 2022-10-03
• Last updated: 2025-01-22

Locations

1 site across 1 country: Ireland